Evidence map›Paper›PMID 21179036›Full record

ArticleBritish journal of cancer2011

A prospective study of chemotherapy-induced febrile neutropenia in the South West London Cancer Network. Interpretation of study results in light of NCAG/NCEPOD findings.

M Okera, S Chan, U Dernede, J Larkin, S Popat, D Gilbert, L Jones, N Osuji, H Sykes, C Oakley and 3 more

Open access · hybridAbstract read
In one paragraph

Article in British journal of cancer, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Antiemetic and Myeloprotective Effects ofEvidence-based complementary and alternative medicine : eCAM · 2017
    Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

M OkeraDepartment of Medical Oncology, Guy's & St Thomas' NHS Foundation Trust, Great Maze Pond, London SE1 9RT, UK.
S Chan
U Dernede
J Larkin
S Popat
D Gilbert
L Jones
N Osuji
H Sykes
C Oakley
L Pickering
F Lofts
S Chowdhury
Guy's and St Thomas' NHS Foundation Trust · GBRoyal Marsden NHS Foundation Trust · GBSt George's Hospital · GBCroydon University Hospital · GBEpsom and St Helier University Hospitals NHS Trust · GBKingston Hospital NHS Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChemotherapy-induced febrile neutropenia is a medical emergency complicating the treatment of many cancer patients. It is associated with considerable morbidity and mortality, as well as impacting on healthcare resources.

methodsA prospective study of all cases of chemotherapy-induced febrile neutropenia in the South West London Cancer Network was conducted over a 4-month period. Factors including demographics, treatment history, management of febrile neutropenia and outcome were recorded. RESULTS AND

conclusionOur results reflect those of the recent National Chemotherapy Advisory Group (NCEPOD, 2008)/National Confidential Enquiry into Patient Outcomes and Death reports (NCAG, 2009) and highlight the need for network-wide clinical care pathways to improve outcomes in this area.

Indexed as

AdultAgedAntineoplastic AgentsDatabases, FactualFemaleFeverHumansMaleMiddle AgedNeoplasmsNeutropeniaProspective StudiesRisk FactorsYoung AdultAntineoplastic Agents

Identifiers

PMID21179036
PMCPMC3049562
OpenAlexW1981551527

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.